Medtronic (MDT) reported Q4 FY 2019 earnings of $1.54 per share (versus $1.42 in Q4 FY 2018), beating analysts’ consensus of $1.47.
The company’s quarterly revenues amounted to $8.146 bln (0.0% y/y), generally in line with analysts’ consensus estimate of $8.121 bln.
The company also issued upside guidance for FY 2020, projecting EPS of $5.44-5.50 (versus analysts’ consensus estimate of $5.43) and revenue growth to approximate 4.0 percent on an organic basis.
MDT rose to $90.90 (+2.41%) in pre-market trading.